Request Sample Inquiry
Monoclonal Antibodies Market

Monoclonal Antibodies Market

Monoclonal Antibodies Market - Global Industry Assessment & Forecast

img
Healthcare
Number Of Pages # Pages:

146

Base Year:

2022

Date

Jun - 2022

Format:

PDF XLS PPT

Report Code:

VMR-1673

Segments Covered
  • By Source By Source Murine, Chimeric, Humanized, Human
  • By Indication By Indication Cancer, Autoimmune Diseases, Inflammatory Diseases, Infectious Diseases, Others
  • By End User By End User Hospitals, Research Institutes, Others
  • By Region By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
Base YearBase Year: 2022
Forecast YearsForecast Years: 2023 - 2030
Historical YearsHistorical Years: 2017 - 2021
Revenue 2022Revenue 2022: USD 111.93 Billion
Revenue 2030Revenue 2030: USD 186.67 Billion
Revenue CAGRRevenue CAGR (2023 - 2030): 6.60%
Fastest Growing Region Fastest Growing Region (2023 - 2030) Asia Pacific
Largest Region Largest Region (2022): North America
Customization Offered
  • Cross-segment Market Size and Analysis for Mentioned Segments Cross-segment Market Size and Analysis for Mentioned Segments
  • Additional Company Profiles (Upto 5 With No Cost) Additional Company Profiles (Upto 5 With No Cost)
  • Additional Countries (Apart From Mentioned Countries) Additional Countries (Apart From Mentioned Countries)
  • Country/Region-specific Report Country/Region-specific Report
  • Go To Market Strategy Go To Market Strategy
  • Region Specific Market Dynamics Region Specific Market Dynamics
  • Region Level Market Share Region Level Market Share
  • Import Export Analysis Import Export Analysis
  • Production Analysis Production Analysis
  • Other Others Request Customization Speak To Analyst
  1. Executive Dashboard
    1. Strategic Imperatives
  2. Premium Insights
    1. Top 3 Trends to Watch
    2. Demand and Supply Trends
    3. Top 3 Strategies Followed by Major Players
    4. Top 3 Predictions by Vantage Market Research
    5. Top Investment Pockets
    6. Insights from Primary Respondents
  3. Global Monoclonal Antibodies Market - Segment Analysis
    1. Overview
    2. Global Monoclonal Antibodies Market, 2016 - 2028 (USD Million)
    3. Global Monoclonal Antibodies Market - by Source
      1. By Murine
      2. By Chimeric
      3. By Humanized
      4. By Human
    4. Global Monoclonal Antibodies Market - by Indication
      1. By Cancer
      2. By Autoimmune Diseases
      3. By Inflammatory Diseases
      4. By Infectious Diseases
      5. By Others
    5. Global Monoclonal Antibodies Market - by End User
      1. By Hospitals
      2. By Research Institutes
      3. By Others
    6. Global Monoclonal Antibodies Market - by region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
    7. Market comparative analysis
  4. North America Monoclonal Antibodies Market - Segment Analysis
    1. Overview
    2. North America Monoclonal Antibodies Market, 2016 - 2028 (USD Million)
    3. North America Monoclonal Antibodies Market, by Source
      1. By Murine
      2. By Chimeric
      3. By Humanized
      4. By Human
    4. North America Monoclonal Antibodies Market, by Indication
      1. By Cancer
      2. By Autoimmune Diseases
      3. By Inflammatory Diseases
      4. By Infectious Diseases
      5. By Others
    5. North America Monoclonal Antibodies Market, by End User
      1. By Hospitals
      2. By Research Institutes
      3. By Others
    6. North America Monoclonal Antibodies Market, by Country
      1. U.S.
        1. U.S. Monoclonal Antibodies Market, By Source
          1. By Murine
          2. By Chimeric
          3. By Humanized
          4. By Human
        2. U.S. Monoclonal Antibodies Market, By Indication
          1. By Cancer
          2. By Autoimmune Diseases
          3. By Inflammatory Diseases
          4. By Infectious Diseases
          5. By Others
        3. U.S. Monoclonal Antibodies Market, By End User
          1. By Hospitals
          2. By Research Institutes
          3. By Others
      2. Canada
        1. Canada Monoclonal Antibodies Market, By Source
          1. By Murine
          2. By Chimeric
          3. By Humanized
          4. By Human
        2. Canada Monoclonal Antibodies Market, By Indication
          1. By Cancer
          2. By Autoimmune Diseases
          3. By Inflammatory Diseases
          4. By Infectious Diseases
          5. By Others
        3. Canada Monoclonal Antibodies Market, By End User
          1. By Hospitals
          2. By Research Institutes
          3. By Others
      3. Mexico
        1. Mexico Monoclonal Antibodies Market, By Source
          1. By Murine
          2. By Chimeric
          3. By Humanized
          4. By Human
        2. Mexico Monoclonal Antibodies Market, By Indication
          1. By Cancer
          2. By Autoimmune Diseases
          3. By Inflammatory Diseases
          4. By Infectious Diseases
          5. By Others
        3. Mexico Monoclonal Antibodies Market, By End User
          1. By Hospitals
          2. By Research Institutes
          3. By Others
  5. Europe Monoclonal Antibodies Market - Segment Analysis
    1. Overview
    2. Europe Monoclonal Antibodies Market, 2016 - 2028 (USD Million)
    3. Europe Monoclonal Antibodies Market, by Source
      1. By Murine
      2. By Chimeric
      3. By Humanized
      4. By Human
    4. Europe Monoclonal Antibodies Market, by Indication
      1. By Cancer
      2. By Autoimmune Diseases
      3. By Inflammatory Diseases
      4. By Infectious Diseases
      5. By Others
    5. Europe Monoclonal Antibodies Market, by End User
      1. By Hospitals
      2. By Research Institutes
      3. By Others
    6. Europe Monoclonal Antibodies Market, by Country
      1. Germany
        1. Germany Monoclonal Antibodies Market, By Source
          1. By Murine
          2. By Chimeric
          3. By Humanized
          4. By Human
        2. Germany Monoclonal Antibodies Market, By Indication
          1. By Cancer
          2. By Autoimmune Diseases
          3. By Inflammatory Diseases
          4. By Infectious Diseases
          5. By Others
        3. Germany Monoclonal Antibodies Market, By End User
          1. By Hospitals
          2. By Research Institutes
          3. By Others
      2. UK
        1. UK Market, By Source
          1. By Murine
          2. By Chimeric
          3. By Humanized
          4. By Human
        2. UK Market, By Indication
          1. By Cancer
          2. By Autoimmune Diseases
          3. By Inflammatory Diseases
          4. By Infectious Diseases
          5. By Others
        3. UK Market, By End User
          1. By Hospitals
          2. By Research Institutes
          3. By Others
      3. France
        1. France Monoclonal Antibodies Market, By Source
          1. By Murine
          2. By Chimeric
          3. By Humanized
          4. By Human
        2. France Monoclonal Antibodies Market, By Indication
          1. By Cancer
          2. By Autoimmune Diseases
          3. By Inflammatory Diseases
          4. By Infectious Diseases
          5. By Others
        3. France Monoclonal Antibodies Market, By End User
          1. By Hospitals
          2. By Research Institutes
          3. By Others
      4. Spain
        1. Spain Monoclonal Antibodies Market, By Source
          1. By Murine
          2. By Chimeric
          3. By Humanized
          4. By Human
        2. Spain Monoclonal Antibodies Market, By Indication
          1. By Cancer
          2. By Autoimmune Diseases
          3. By Inflammatory Diseases
          4. By Infectious Diseases
          5. By Others
        3. Spain Monoclonal Antibodies Market, By End User
          1. By Hospitals
          2. By Research Institutes
          3. By Others
      5. Italy
        1. Italy Monoclonal Antibodies Market, By Source
          1. By Murine
          2. By Chimeric
          3. By Humanized
          4. By Human
        2. Italy Monoclonal Antibodies Market, By Indication
          1. By Cancer
          2. By Autoimmune Diseases
          3. By Inflammatory Diseases
          4. By Infectious Diseases
          5. By Others
        3. Italy Monoclonal Antibodies Market, By End User
          1. By Hospitals
          2. By Research Institutes
          3. By Others
      6. BENELUX
        1. BENELUX Monoclonal Antibodies Market, By Source
          1. By Murine
          2. By Chimeric
          3. By Humanized
          4. By Human
        2. BENELUX Monoclonal Antibodies Market, By Indication
          1. By Cancer
          2. By Autoimmune Diseases
          3. By Inflammatory Diseases
          4. By Infectious Diseases
          5. By Others
        3. BENELUX Monoclonal Antibodies Market, By End User
          1. By Hospitals
          2. By Research Institutes
          3. By Others
      7. Rest of Europe
        1. Rest Of Europe Monoclonal Antibodies Market, By Source
          1. By Murine
          2. By Chimeric
          3. By Humanized
          4. By Human
        2. Rest Of Europe Monoclonal Antibodies Market, By Indication
          1. By Cancer
          2. By Autoimmune Diseases
          3. By Inflammatory Diseases
          4. By Infectious Diseases
          5. By Others
        3. Rest Of Europe Monoclonal Antibodies Market, By End User
          1. By Hospitals
          2. By Research Institutes
          3. By Others
  6. Asia Pacific Monoclonal Antibodies Market - Segment Analysis
    1. Overview
    2. Asia Pacific Monoclonal Antibodies Market, 2016 - 2028 (USD Million)
    3. Asia Pacific Monoclonal Antibodies Market, by Source
      1. By Murine
      2. By Chimeric
      3. By Humanized
      4. By Human
    4. Asia Pacific Monoclonal Antibodies Market, by Indication
      1. By Cancer
      2. By Autoimmune Diseases
      3. By Inflammatory Diseases
      4. By Infectious Diseases
      5. By Others
    5. Asia Pacific Monoclonal Antibodies Market, by End User
      1. By Hospitals
      2. By Research Institutes
      3. By Others
    6. Asia Pacific Monoclonal Antibodies Market, by Country
      1. China
        1. China Monoclonal Antibodies Market, By Source
          1. By Murine
          2. By Chimeric
          3. By Humanized
          4. By Human
        2. China Monoclonal Antibodies Market, By Indication
          1. By Cancer
          2. By Autoimmune Diseases
          3. By Inflammatory Diseases
          4. By Infectious Diseases
          5. By Others
        3. China Monoclonal Antibodies Market, By End User
          1. By Hospitals
          2. By Research Institutes
          3. By Others
      2. Japan
        1. Japan Monoclonal Antibodies Market, By Source
          1. By Murine
          2. By Chimeric
          3. By Humanized
          4. By Human
        2. Japan Monoclonal Antibodies Market, By Indication
          1. By Cancer
          2. By Autoimmune Diseases
          3. By Inflammatory Diseases
          4. By Infectious Diseases
          5. By Others
        3. Japan Monoclonal Antibodies Market, By End User
          1. By Hospitals
          2. By Research Institutes
          3. By Others
      3. India
        1. India Monoclonal Antibodies Market, By Source
          1. By Murine
          2. By Chimeric
          3. By Humanized
          4. By Human
        2. India Monoclonal Antibodies Market, By Indication
          1. By Cancer
          2. By Autoimmune Diseases
          3. By Inflammatory Diseases
          4. By Infectious Diseases
          5. By Others
        3. India Monoclonal Antibodies Market, By End User
          1. By Hospitals
          2. By Research Institutes
          3. By Others
      4. South Korea
        1. South Korea Monoclonal Antibodies Market, By Source
          1. By Murine
          2. By Chimeric
          3. By Humanized
          4. By Human
        2. South Korea Monoclonal Antibodies Market, By Indication
          1. By Cancer
          2. By Autoimmune Diseases
          3. By Inflammatory Diseases
          4. By Infectious Diseases
          5. By Others
        3. South Korea Monoclonal Antibodies Market, By End User
          1. By Hospitals
          2. By Research Institutes
          3. By Others
      5. South East Asia
        1. South East Asia Monoclonal Antibodies Market, By Source
          1. By Murine
          2. By Chimeric
          3. By Humanized
          4. By Human
        2. South East Asia Monoclonal Antibodies Market, By Indication
          1. By Cancer
          2. By Autoimmune Diseases
          3. By Inflammatory Diseases
          4. By Infectious Diseases
          5. By Others
        3. South East Asia Monoclonal Antibodies Market, By End User
          1. By Hospitals
          2. By Research Institutes
          3. By Others
      6. Rest of Asia Pacific
        1. Rest of Asia Pacific Monoclonal Antibodies Market, By Source
          1. By Murine
          2. By Chimeric
          3. By Humanized
          4. By Human
        2. Rest of Asia Pacific Monoclonal Antibodies Market, By Indication
          1. By Cancer
          2. By Autoimmune Diseases
          3. By Inflammatory Diseases
          4. By Infectious Diseases
          5. By Others
        3. Rest of Asia Pacific Monoclonal Antibodies Market, By End User
          1. By Hospitals
          2. By Research Institutes
          3. By Others
  7. Latin America Monoclonal Antibodies Market - Segment Analysis
    1. Overview
    2. Latin America Monoclonal Antibodies Market, 2016 - 2028 (USD Million)
    3. Latin America Monoclonal Antibodies Market, by Source
      1. By Murine
      2. By Chimeric
      3. By Humanized
      4. By Human
    4. Latin America Monoclonal Antibodies Market, by Indication
      1. By Cancer
      2. By Autoimmune Diseases
      3. By Inflammatory Diseases
      4. By Infectious Diseases
      5. By Others
    5. Latin America Monoclonal Antibodies Market, by End User
      1. By Hospitals
      2. By Research Institutes
      3. By Others
    6. Latin America Monoclonal Antibodies Market, by Country
      1. Brazil
        1. Brazil Monoclonal Antibodies Market, By Source
          1. By Murine
          2. By Chimeric
          3. By Humanized
          4. By Human
        2. Brazil Monoclonal Antibodies Market, By Indication
          1. By Cancer
          2. By Autoimmune Diseases
          3. By Inflammatory Diseases
          4. By Infectious Diseases
          5. By Others
        3. Brazil Monoclonal Antibodies Market, By End User
          1. By Hospitals
          2. By Research Institutes
          3. By Others
      2. Argentina
        1. Argentina Monoclonal Antibodies Market, By Source
          1. By Murine
          2. By Chimeric
          3. By Humanized
          4. By Human
        2. Argentina Monoclonal Antibodies Market, By Indication
          1. By Cancer
          2. By Autoimmune Diseases
          3. By Inflammatory Diseases
          4. By Infectious Diseases
          5. By Others
        3. Argentina Monoclonal Antibodies Market, By End User
          1. By Hospitals
          2. By Research Institutes
          3. By Others
      3. Rest of Latin America
        1. Rest of Latin America Monoclonal Antibodies Market, By Source
          1. By Murine
          2. By Chimeric
          3. By Humanized
          4. By Human
        2. Rest of Latin America Monoclonal Antibodies Market, By Indication
          1. By Cancer
          2. By Autoimmune Diseases
          3. By Inflammatory Diseases
          4. By Infectious Diseases
          5. By Others
        3. Rest of Latin America Monoclonal Antibodies Market, By End User
          1. By Hospitals
          2. By Research Institutes
          3. By Others
  8. Middle East & Africa Monoclonal Antibodies Market - Segment Analysis
    1. Overview
    2. Middle East & Africa Monoclonal Antibodies Market, 2016 - 2028 (USD Million)
    3. Middle East & Africa Monoclonal Antibodies Market, by Source
      1. By Murine
      2. By Chimeric
      3. By Humanized
      4. By Human
    4. Middle East & Africa Monoclonal Antibodies Market, by Indication
      1. By Cancer
      2. By Autoimmune Diseases
      3. By Inflammatory Diseases
      4. By Infectious Diseases
      5. By Others
    5. Middle East & Africa Monoclonal Antibodies Market, by End User
      1. By Hospitals
      2. By Research Institutes
      3. By Others
    6. Middle East & Africa Monoclonal Antibodies Market, by Country
      1. GCC Countries
        1. GCC Countries Monoclonal Antibodies Market, By Source
          1. By Murine
          2. By Chimeric
          3. By Humanized
          4. By Human
        2. GCC Countries Monoclonal Antibodies Market, By Indication
          1. By Cancer
          2. By Autoimmune Diseases
          3. By Inflammatory Diseases
          4. By Infectious Diseases
          5. By Others
        3. GCC Countries Monoclonal Antibodies Market, By End User
          1. By Hospitals
          2. By Research Institutes
          3. By Others
      2. South Africa
        1. South Africa Monoclonal Antibodies Market, By Source
          1. By Murine
          2. By Chimeric
          3. By Humanized
          4. By Human
        2. South Africa Monoclonal Antibodies Market, By Indication
          1. By Cancer
          2. By Autoimmune Diseases
          3. By Inflammatory Diseases
          4. By Infectious Diseases
          5. By Others
        3. South Africa Monoclonal Antibodies Market, By End User
          1. By Hospitals
          2. By Research Institutes
          3. By Others
      3. Rest of Middle East & Africa
        1. Rest of Middle East & Africa Monoclonal Antibodies Market, By Source
          1. By Murine
          2. By Chimeric
          3. By Humanized
          4. By Human
        2. Rest of Middle East & Africa Monoclonal Antibodies Market, By Indication
          1. By Cancer
          2. By Autoimmune Diseases
          3. By Inflammatory Diseases
          4. By Infectious Diseases
          5. By Others
        3. Rest of Middle East & Africa Monoclonal Antibodies Market, By End User
          1. By Hospitals
          2. By Research Institutes
          3. By Others
  9. Key Market Dynamics
    1. Introduction
    2. Market Drivers
    3. Market Restraints
    4. Market Opportunities
    5. Porter's Five Forces Analysis
    6. PEST Analysis
    7. Regulatory Landscape
    8. Technology Landscape
    9. Regional Market Trends
  10. COVID 19 Impact Analysis
    1. Key strategies undertaken by companies to tackle COVID-19
    2. Short term dynamics
    3. Long term dynamics
  11. Marketing Stratagy Analysis
    1. Marketing Channel
    2. Direct Marketing
    3. Indirect Marketing
    4. Marketing Channel Development Trends
  12. Competative Landscape
    1. Competition Matrix - 2021
    2. Company Market Share Analysis - 2021
    3. Key Company Activities, 2018 - 2021
    4. Strategic Developments - Heat Map Analysis
    5. Company Offering Evaluation
    6. Company Regional Presence Evaluation
  13. Company Profiles
    1. Abbott Laboratories
    2. Amgen Inc.
    3. AstraZeneca PLC
    4. Bayer AG
    5. Eli Lilly
    6. GlaxoSmithKline PLC
    7. Johnson & Johnson
    8. Merck & Co. Inc.
    9. Novartis
    10. Pfizer
  14. Key Primary Respondents - VERBATIM
  15. Discussion Guide
  16. Customization Offered
  17. Annexure
  18. List of Figures
  19. List of Tables
  20. List of Abbreviations
Vantage Market Research | 27-Jun-2022
Monoclonal Antibodies Market to Reach Valuation of USD 155.2 Billion by 2028 – Growth in Technological Advancements in the Field of Genomics Drives the Market
FAQ
Frequently Asked Question

  • The global Monoclonal Antibodies valued at USD 111.93 Billion in 2022 and is expected to reach USD 186.67 Billion in 2030 growing at a CAGR of 6.60%.

  • The prominent players in the market are Abbott Laboratories, Amgen Inc., AstraZeneca PLC, Bayer AG, Eli Lilly, GlaxoSmithKline PLC, Johnson & Johnson, Merck & Co. Inc., Novartis, Pfizer.

  • The market is project to grow at a CAGR of 6.60% between 2023 and 2030.

  • The driving factors of the Monoclonal Antibodies include

    • Rise in prevalence of various cancer types

  • North America was the leading regional segment of the Monoclonal Antibodies in 2022.

Related Reports
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies Privacy Policy